PacBio’s Compatible partner program recognizes third-party providers whose solutions have been evaluated to work seamlessly with PacBio instruments and data formats. As a named partner, Lucid Genomics ...
SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.
Amid rising demand for digital and technology-driven skills, Harvard University has made several of its courses accessible online at no cost through its learning platform. The offerings span key areas ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population. The ...
Invivyd Inc. (NASDAQ:IVVD) is one of the best NASDAQ growth stocks to buy and hold forever. On April 9, Invivyd announced ...
New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...
A comprehensive guide to crypto programming in 2026, covering essential languages, smart contract development, DeFi applications ...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced its participation in the ...
Military contractor Palantir has been paid more than $130 million by the IRS to analyze sensitive federal databases.
The PIS elicited a potent immune response as measured by local skin tests and immunological assays.
Privacy and ethics while matching data with locations were hot topics during Friday’s panel discussion on GIS technology and ...
Synopsys is working with EMA and Cesium, part of Bentley Systems, to test equipment functionality by virtually replicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results